Vibrating shoe improves walking stability
- Trial ID
- NCT06975059
- Official Title
- Using the NUSHU Shoe to Analyze Gait Balance and Vibrotactile Feedback in Early, Moderate and Advanced PD Patients and Healthy Controls
- Goal
- Vibrating shoe improves walking stability
- Phase
- NA
- Status
- RECRUITING
- Sponsor
- Weill Medical College of Cornell University
- Study Type
- INTERVENTIONAL
- Enrollment
- 40 participants
- Conditions
- Parkinson's Disease (PD)
- Interventions
- NUSHU shoe
Summary For Families
The goal is to map how gait and balance change across early, moderate, and advanced Parkinson's, and to test whether vibrotactile foot cues from the NUSHU shoe can improve stability and step timing. The approach uses a sensor-packed, wearable shoe that records steps, sway, and asymmetry while delivering timed vibrations to the foot to provide rhythmic cues that may help with balance and gait, it is noninvasive and designed to be used alongside usual medications like levodopa rather than replace them. Eligible participants are adults 18 and older with a PD diagnosis who can walk independently and score 22 or higher on the MoCA, and the study also enrolls healthy adults 18 and older with no neurological disease; people who cannot wear the device or have other major brain or gait disorders are excluded.
Locations
- Weill Cornell, New York, New York, United States
Frequently Asked Questions
- What is this trial testing?
- This trial is studying NUSHU shoe. The goal is to map how gait and balance change across early, moderate, and advanced Parkinson's, and to test whether vibrotactile foot cues from the NUSHU shoe can improve stability and step timing. The approach uses a sensor-packed, wearable shoe that records steps, sway, and asymmetry while delivering timed vibrations to the foot to provide rhythmic cues that may help with balance and gait, it is noninvasive and designed to be used alongside usual medications like levodopa rather than replace them. Eligible participants are adults 18 and older with a PD diagnosis who can walk independently and score 22 or higher on the MoCA, and the study also enrolls healthy adults 18 and older with no neurological disease; people who cannot wear the device or have other major brain or gait disorders are excluded.
- Who can participate?
- Participants must be at least 18 Years.
- Where is this trial located?
- This trial is recruiting at 1 location.
- Does it cost anything to join?
- No. There is no cost to participate. Study-related care and treatment are provided at no charge.
- How long does the trial last?
- This trial is estimated to last approximately 2 years and 1 month.
- Will I get the real drug or a placebo?
- It depends on the trial design. Some Parkinson's trials are placebo controlled, meaning a portion of participants get an inactive comparison while others get the experimental treatment. Some use crossover designs so everyone eventually receives the active treatment at some point. Observational trials do not use a placebo at all because they are not testing a new treatment. The consent form for any specific trial spells out the design and your odds of being assigned to placebo before you enroll.
- How often will I need to visit the study site?
- Visit frequency varies by trial. Many Parkinson's studies require an in person visit every 4 to 12 weeks during the active treatment phase, with shorter or longer gaps depending on the design. The site coordinator can give you the full visit schedule before you sign anything, so you know what the time commitment looks like.
- Can I leave the trial if I change my mind?
- Yes. You can withdraw from any clinical trial at any time, for any reason, without affecting your standard medical care. Trials are voluntary by law. The team may ask if you are willing to do a brief exit visit so they can collect safety information, but you are not obligated.
- Will travel or parking be reimbursed?
- Many trials reimburse for parking, mileage, and sometimes lodging if the site is far from your home. Reimbursement policies vary by sponsor and site. When you contact the trial team, ask specifically what is covered and how reimbursement is processed.
- Can my spouse or care partner come with me to visits?
- In most cases yes, and it is often encouraged. Care partners can help with notes, questions, and getting home safely after a long visit. Some study assessments do need to happen one on one, but care partners are usually welcome for the rest of the appointment.